People
  1. Students
  2. Alumni
  3. Honorary Graduates
  4. Academic Experts
People

portrait of Professor Amanda Burls

Professor Amanda Burls

Public Health Physician

School of Health Sciences, Division of Health Services Research & Management

Contact Information

Contact

Visit Amanda Burls

M130, Myddelton Street Building

null

Postal Address

City, University of London
Northampton Square
London
EC1V 0HB
United Kingdom

About

Overview

Public Health Physician, with special interest in Evidence-Based Health Care and Public and Patient involvement in Health Care and Health Research.

Amanda Burls' first degree was in Politics, Philosophy and Economic from the University of Oxford but she later went on to study Medicine at University College London. During her medical degree she intercalated an MSc in Neuroscience. Following several junior and senior house office jobs she undertook five years specialist training in Public Health Medicine during which she obtained a Masters in Public Health from the London School of Hygiene and Tropical Medicine. She worked for the Critical Appraisal Skills Programme (CASP) from its inception in 1993 and in 1996 became its Director. She has been a senior fellow of the Centre for Evidence-Based Medicine since 1996 where she coordinates and facilitates the Spanish-speaking groups and runs plenary sessions on teaching EBHC.

In 1997 Amanda started as a Senior Clinical Lecturer at the University of Birmingham where she founded and directed the West Midlands Health Technology Assessment Collaboration (WMHTAC). WMHTAC produced systematic reviews and economic evaluations to inform local, regional and national health policy decisions. In 2008 Amanda moved to the University of Oxford as Director of Postgraduate Programmes in Evidence-Based Health Care. She set up the Oxford International Programme in Evidence-Based Health Care which includes Certificate, Diploma, MSc and Doctoral Programmes as well as standalone modules.

Amanda's current research focuses on EBHC, online health research and public and patient involvement in health care and health research and she directs a project called ThinkWell.

Qualifications

BA in PPE; MSc in Neuroscience; MSc in Public Health; MB BS; FPH

Awards

- 2012 The Egon Jonsson Award for the most outstanding paper in the International Journal of Technology Assessment in Health Care (Burls A, Caron L, Cleret de Langavant G, Dondorp W, Harstall C, Pathak-Sen E, Hofmann B. Tackling Ethical Issues in HTA: A Proposed Framework. 2011 27 (3):230-237)

- 2012 Oxford University Students' Award for Innovation in Teaching (plus runner up for Best Lecturer)

- 2012 Silicon Valley Comes to Oxford best health project proposal, which was about Public-Led Online Randomized Trials, this was also a highly commended amongst all the project proposals.

- 2012 "Organizational Safety Culture Survey Reliability and Validity" Highly Commended Award winner of the Emerald/CLADEA Latin American Management Research Fund Award. http://www.emeraldinsight.com/research/awards/latin_man_2012.htm

- 2009 Oxford University Teaching Excellence Award (MSc in EBHC) ; 2009 OxTALENT Award (Oxford Teaching & Learning Enhanced by New Technology)

- 2010 Clinical Excellence Award - National Level Bronze

- 2005 Clinical Excellence Award - National Level Bronze

- 1995 BMA Joan Dawkins Travel Fellowship

- 1993 Distinction, MSc in Public Health Medicine

- 1990 Certificate of Merit in Medicine

- 1990 Jenner-Living Prize in Dermatology

- 1989-90 Prankerd-Jones Award

- 1987-88 Ferriere Scholarship

Languages

Spanish

Memberships of professional bodies

- Fellow of the Faculty of Public Health

Research

Research areas

- Systematic Reviews; Evidence-Based Practice
- Online Health Research; Internet Randomised Controlled Trials
- Public and Patient Involvement
- Health Technology Assessment
- The Ethics of Public Health and Prioritisation.

Publications

Chapter

  1. Bryan, S., Sandercock, J., Barton, P. and Burls, A. (2007). Tensions in Licensing and Reimbursement Decisions: The Case of Riluzole for Amytrophic Lateral Sclerosis. Evaluating Pharmaceuticals for Health Policy and Reimbursement (pp. 121–138). ISBN 978-0-470-99471-9.

Conference Papers and Proceedings (6)

  1. Kang, J.H.E., Di Carlo, S., Iaculli, E., Burls, A. and Silva, M.A. (2013). Informed consent for laparoscopic cholecystectomy and patient awareness of possible complications in emergency and elective settings. .
  2. Jensen, A.M., Stevens, R., Burls, A., Kenealy, T. and Stewart, J. (2012). Is Muscle Testing a Form of Biofeedback?: Results from a Diagnostic Test Accuracy Study. .
  3. Saunders, P.J., Burls, A. and Hood, A. (2012). Developing On Line Resource for Expressing and Explaining Risks for the Public and Professionals. .
  4. Quinn, T., Burls, A.J., Bayliss, S., Emperanza, J. and Cabello Lopez, J. (2009). Does oxygen therapy do more harm than good in acute MI? Systematic review. .
  5. Quinn, T., Burls, A., Emparanza, J. and Cabello, J. (2009). Oxygen use in acute myocardial infarction: online survey of health professionals' practice and beliefs. .
  6. Douglas, K.M.J., Wilson, J., Burls, A. and Jobanputra, P. (2003). A SURVEY OF DMARD PREFERENCES OF UK RHEUMATOLOGISTS. .

Journal Articles (120)

  1. Ruiz Garcia, V., Burls, A., Cabello, J.B., Vela Casasempere, P., Bort-Marti, S. and Bernal, J.A. (2017). Certolizumab pegol (CDP870) for rheumatoid arthritis in adults. Cochrane Database of Systematic Reviews, 2017(9) . doi:10.1002/14651858.CD007649.pub4.
  2. Castle, J.C., Chalmers, I., Atkinson, P., Badenoch, D., Oxman, A.D., Austvoll-Dahlgren, A., Nordheim, L., Krause, L.K., Schwartz, L.M., Woloshin, S., Burls, A., Mosconi, P., Hoffmann, T., Cusack, L., Albarqouni, L. and Glasziou, P. (2017). Establishing a library of resources to help people understand key concepts in assessing treatment claims - The “Critical thinking and Appraisal Resource Library” (CARL). PLoS ONE, 12(7) . doi:10.1371/journal.pone.0178666.
  3. Cabello, J.B., Burls, A., Emparanza, J.I., Bayliss, S.E. and Quinn, T. (2016). Oxygen therapy for acute myocardial infarction. Cochrane Database of Systematic Reviews, 2016(12) . doi:10.1002/14651858.CD007160.pub4.
  4. Jensen, A.M., Stevens, R.J. and Burls, A.J. (2016). Estimating the accuracy of muscle response testing: Two randomised-order blinded studies. BMC Complementary and Alternative Medicine, 16(1) . doi:10.1186/s12906-016-1416-2.
  5. Baird, M.A.H., Barlev, N., Bryder, L., Burls, A., Carrell, R.W., Chalmers, I., Cooper, G.J.S., Obs, D., Dow, D.A., Hicks, K., Keirse, M., Mantell, C., Nobbs, P., Overton, E., Overton, H., Patten, P., Sandercock, J., Smith, V. and Trubuhovich, R. (2016). Misrepresentation of the National Women's Hospital in Auckland, New Zealand. American Journal of Public Health, 106(7), pp. 1208–1209. doi:10.2105/AJPH.2016.303162.
  6. Burls, A., Price, A.I., Cabello, J.B. and Roberts, N.W. (2016). Drinking extra water or other non-caloric beverages for promoting weight loss or preventing weight gain. Cochrane Database of Systematic Reviews, 2016(5) . doi:10.1002/14651858.CD012211.
  7. Alabed, S., Pérez-Gaxiola, G. and Burls, A. (2016). Colchicine for children with pericarditis: Systematic review of clinical studies. Archives of Disease in Childhood . doi:10.1136/archdischild-2015-310287.
  8. Mosconi, P., Antes, G., Barbareschi, G., Burls, A., Demotes-Mainard, J., Chalmers, I., Colombo, C., Garattini, S., Gluud, C., Gyte, G., Mcllwain, C., Penfold, M., Post, N., Satolli, R., Valetto, M.R., West, B. and Wolff, S. (2016). A European multi-language initiative to make the general population aware of independent clinical research: The European Communication on Research Awareness Need project. Trials, 17(1) . doi:10.1186/s13063-015-1146-7.
  9. Ban, J.W., Emparanza, J.I., Urreta, I. and Burls, A. (2016). Design characteristics influence performance of clinical prediction rules in validation: A meta-epidemiological study. PLoS ONE, 11(1) . doi:10.1371/journal.pone.0145779.
  10. Emparanza, J.I., Cabello, J.B. and Burls, A. (2015). Does evidence-based practice improve patient outcomes. Journal of Evaluation in Clinical Practice, 21(6), pp. 1059–1605. doi:10.1111/jep.12460.
  11. Price, A. and Burls, A. (2015). Increased water intake to reduce headache: Learning from a critical appraisal. Journal of Evaluation in Clinical Practice, 21(6), pp. 1212–1218. doi:10.1111/jep.12413.
  12. Emparanza, J.I., Cabello, J.B. and Burls, A.J.E. (2015). Does evidence-based practice improve patient outcomes? An analysis of a natural experiment in a Spanish hospital. Journal of Evaluation in Clinical Practice, 21(6), pp. 1059–1065. doi:10.1111/jep.12460.
  13. Brice, A., Price, A. and Burls, A. (2015). Creating a database of internet-based clinical trials to support a public-led research programme: A descriptive analysis. DIGITAL HEALTH, 1, pp. 205520761561785–205520761561785. doi:10.1177/2055207615617854.
  14. O'Malley, G., Killeen, S., Brinkley, A., Sheridan, N., Kelly, N., Doyle, S., Burls, A., Clarke, M., Carroll, A., Perry, I.J., Murphy, N. and Murphy, S. (2015). CARDIOMETABOLIC COMORBIDITY IN CHILD AND ADOLESCENT OBESITY. ACTA PAEDIATRICA, 104, pp. 25–25.
  15. O'Malley, G., Murphy, S., Brinkley, A., Perry, I.J., Clarke, M. and Burls, A. (2015). MHEALTH INTERVENTIONS FOR CHILD AND ADOLESCENT OBESITY. ACTA PAEDIATRICA, 104, pp. 17–17.
  16. (2015). Cochrane corner: Colchicine for pericarditis. Heart . doi:10.1136/heartjnl-2015-307780.
  17. Price, A. and Burls, A. (2015). Increased water intake to reduce headache: Learning from a critical appraisal. Journal of Evaluation in Clinical Practice . doi:10.1111/jep.12413.
  18. Chen, Y., Chalmers, I., Essali, A., Rezk, E., Yang, K., Wang, Q., Yao, L., Antes, G., Ledinek, S., Glasziou, P., Badenoch, D., Atkinson, P., Penfold, M., Burls, A., Goldacre, B., Gaxiola, G.P., García, V.R., Ubeda, M., Ansuategi, E., Emparanza, J.I., Ravaud, P., Boutron, I., Trinquart, A.D.L., Diard, E., Puljak, L., Sapunar, D., D'Amico, R., Mosconi, P., Annoni, M., Balduzzi, S., Colombo, C., Formoso, G., Martini, M., Roberto, A., Olsen, K., Jamtvedt, G., Fretheim, A., Austvoll-Dahlgren, A., Larun, L., Juvet, L.K., Reinar, L.M., Denstad, B.G., Soares-Weiser, K., Grande, A.J., Cardoso, F., Vlassov, V.V., Makretsov, N., Levi, R., Rosén, M.M. and Gülmezoglu, M.M. (2015). Testing treatments interactive (TTi): Helping to equip the public to promote better research for better health care. Journal of Evidence-Based Medicine, 8(2), pp. 98–102. doi:10.1111/jebm.12155.
  19. Emparanza, J.I., Cabello, J.B. and Burls, A.J.E. (2015). Does evidence-based practice improve patient outcomes? An analysis of a natural experiment in a Spanish hospital. Journal of Evaluation in Clinical Practice . doi:10.1111/jep.12460.
  20. Jensen, A.M., Stevens, R. and Burls, A. (2014). Developing the evidence for kinesiology-style manual muscle testing: A series of diagnostic test accuracy studies. Advances in Integrative Medicine . doi:10.1016/j.aimed.2014.10.024.
  21. Jensen, A., Stevens, R. and Burls, A. (2014). Developing the evidence for kinesiology-style manual muscle testing: a series of diagnostic test accuracy studies. J Altern Complement Med, 20(5), p. A95. doi:10.1089/acm.2014.5250.abstract.
  22. O'Malley, G., Clarke, M., Burls, A., Murphy, S., Murphy, N. and Perry, I.J. (2014). A smartphone intervention for adolescent obesity: Study protocol for a randomised controlled non-inferiority trial. Trials, 15(1) . doi:10.1186/1745-6215-15-43.
  23. Panagiotopoulou, N., Nethra, S., Karavolos, S., Ahmad, G., Karabis, A. and Burls, A. (2014). Uterine-sparing minimally invasive interventions in women with uterine fibroids: A systematic review and indirect treatment comparison meta-analysis. Acta Obstetricia et Gynecologica Scandinavica .
  24. Alabed, S., Cabello, J.B., Irving, G.J., Qintar, M. and Burls, A. (2014). Colchicine for pericarditis. The Cochrane database of systematic reviews, 8 .
  25. O'Malley, G., Dowdall, G., Burls, A., Perry, I.J. and Curran, N. (2014). Exploring the usability of a mobile app for adolescent obesity management. Journal of Medical Internet Research, 16(6) . doi:10.2196/mhealth.3262.
  26. Panagiotopoulou, N., Nethra, S., Karavolos, S., Ahmad, G., Karabis, A. and Burls, A. (2014). Uterine-sparing minimally invasive interventions in women with uterine fibroids: A systematic review and indirect treatment comparison meta-analysis. Acta Obstetricia et Gynecologica Scandinavica, 93(9), pp. 858–867. doi:10.1111/aogs.12441.
  27. López-Briz, E., Ruiz Garcia, V., Cabello, J.B., Bort-Marti, S., Carbonell Sanchis, R. and Burls, A. (2014). Heparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adults. The Cochrane database of systematic reviews, 10 . doi:10.1002/14651858.CD008462.pub2.
  28. Ruiz Garcia, V., Jobanputra, P., Burls, A., Cabello, J.B., Vela Casasempere, P., Bort-Marti, S. and Kynaston-Pearson, F.J.B. (2014). Certolizumab pegol (CDP870) for rheumatoid arthritis in adults. The Cochrane database of systematic reviews, 9, p. CD007649. doi:10.1002/14651858.CD007649.pub3.
  29. Cabello, J.B., Burls, A., Emparanza, J.I., Bayliss, S. and Quinn, T. (2013). Oxygen therapy for acute myocardial infarction. The Cochrane database of systematic reviews, 2013(8), pp. CD007160–CD007160. doi:10.1002/14651858.CD007160.pub3.
  30. Panagiotopoulou, N., Nethra, S., Karabis, A., Ahmad, G. and Burls, A. (2013). UTERINE-SPARING SURGICAL TREATMENT MODALITIES IN WOMEN WITH UTERINE FIBROIDS: A SYSTEMATIC REVIEW AND INDIRECT TREATMENT COMPARISON. VALUE IN HEALTH, 16(7), pp. A330–A331.
  31. Lethaby, A., Lopez-Olivo, M.A., Maxwell, L., Burls, A., Tugwell, P. and Wells, G.A. (2013). Etanercept for the treatment of rheumatoid arthritis. Cochrane Database Syst Rev, (5), p. CD004525. doi:10.1002/14651858.CD004525.pub2.
  32. Cabello, J.B., Emparanza, J.I. and Burls, A.J. (2013). Clinical teaching in the 21st Century-the curriculum for evidence-based practice | Una educación para la clínica del siglo xxi: el currículo para la práctica basada en la evidencia. Medicina Clinica .
  33. Powell, J., Hamborg, T., Stallard, N., Burls, A., McSorley, J., Bennett, K., Griffiths, K.M. and Christensen, H. (2012). Effectiveness of a web-based cognitive-behavioral tool to improve mental well-being in the general population: randomized controlled trial. J Med Internet Res, 15(1), p. e2. doi:10.2196/jmir.2240.
  34. Bramis, K., Gordon-Weeks, A.N., Friend, P.J., Bastin, E., Burls, A., Silva, M.A. and Dennison, A.R. (2012). Systematic review of total pancreatectomy and islet autotransplantation for chronic pancreatitis. Br J Surg, 99(6), pp. 761–766. doi:10.1002/bjs.8713.
  35. Burls, A., Cabello, J.B., Emparanza, J.I., Bayliss, S. and Quinn, T. (2011). Oxygen therapy for acute myocardial infarction: a systematic review and meta-analysis. Emerg Med J, 28(11), pp. 917–923. doi:10.1136/emj.2010.103564.
  36. Burls, A. and Sandercock, J. (2011). Decision-making under conditions of uncertainty-what can we learn from palivizumab? Acta Paediatr, 100(10), pp. 1302–1305. doi:10.1111/j.1651-2227.2011.02426.x.
  37. Mickan, S., Burls, A. and Glasziou, P. (2011). Patterns of 'leakage' in the utilisation of clinical guidelines: a systematic review. Postgrad Med J, 87(1032), pp. 670–679. doi:10.1136/pgmj.2010.116012.
  38. Antoniou, E.E., Draper, H., Reed, K., Burls, A., Southwood, T.R. and Zeegers, M.P. (2011). An empirical study on the preferred size of the participant information sheet in research. J Med Ethics, 37(9), pp. 557–562. doi:10.1136/jme.2010.041871.
  39. Gordon-Weeks, A.N., Snaith, A., Petrinic, T., Friend, P.J., Burls, A. and Silva, M.A. (2011). Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria. Br J Surg, 98(9), pp. 1201–1208. doi:10.1002/bjs.7561.
  40. Burls, A., Caron, L., Cleret de Langavant, G., Dondorp, W., Harstall, C., Pathak-Sen, E. and Hofmann, B. (2011). Tackling ethical issues in health technology assessment: a proposed framework. Int J Technol Assess Health Care, 27(3), pp. 230–237. doi:10.1017/S0266462311000250.
  41. Ruiz Garcia, V., Jobanputra, P., Burls, A., Cabello, J.B., Gálvez Muñoz, J.G., Saiz Cuenca, E.S. and Fry-Smith, A. (2011). Certolizumab pegol (CDP870) for rheumatoid arthritis in adults. Cochrane database of systematic reviews (Online), 2 .
  42. Hossain, M., Alexander, P., Burls, A. and Jobanputra, P. (2011). Foot orthoses for patellofemoral pain in adults. Cochrane Database Syst Rev, (1), p. CD008402. doi:10.1002/14651858.CD008402.pub2.
  43. Farrar, D., Duley, L., Burls, A., Dorling, J., Embleton, N., McGuire, W., Oddie, S., Simes, J., Tarnow-Mordi, W., Thornton, J., Tuffnell, D. and Yoxall, B. (2011). Rushing to clamp umbilical cord. More evidence is needed to inform practice. BMJ, 342, p. d122.
  44. Cabello, J.B., Burls, A., Emparanza, J.I., Bayliss, S. and Quinn, T. (2010). Oxygen therapy for acute myocardial infarction. Sao Paulo Medical Journal, 128(6), p. 378. doi:10.1590/S1516-31802010000600013.
  45. Jamtvedt, G., Herbert, R.D., Flottorp, S., Odgaard-Jensen, J., Håvelsrud, K., Barratt, A., Mathieu, E., Burls, A. and Oxman, A.D. (2010). A pragmatic randomised trial of stretching before and after physical activity to prevent injury and soreness. Br J Sports Med, 44(14), pp. 1002–1009. doi:10.1136/bjsm.2009.062232.
  46. Burls, A. (2010). AGREE II-improving the quality of clinical care. Lancet, 376(9747), pp. 1128–1129. doi:10.1016/S0140-6736(10)61034-3.
  47. Sandercock, J. and Burls, A. (2010). Congratulations to the NZMJ for the Unfortunate Experiment theme issue. N Z Med J, 123(1320), pp. 119–120.
  48. Hadley, J., Kulier, R., Zamora, J., Coppus, S.F.P.J., Weinbrenner, S., Meyerrose, B., Decsi, T., Horvath, A.R., Nagy, E., Emparanza, J.I., Arvanitis, T.N., Burls, A., Cabello, J.B., Kaczor, M., Zanrei, G., Pierer, K., Kunz, R., Wilkie, V., Wall, D., Mol, B.W. and Khan, K.S. (2010). Effectiveness of an e-learning course in evidence-based medicine for foundation (internship) training. J R Soc Med, 103(7), pp. 288–294. doi:10.1258/jrsm.2010.100036.
  49. Burls, A. (2010). On the resuscitation of clinical freedom. BMC Health Serv Res, 10, p. 184. doi:10.1186/1472-6963-10-184.
  50. Cabello, J.B., Burls, A., Emparanza, J.I., Bayliss, S. and Quinn, T. (2010). Oxygen therapy for acute myocardial infarction. Cochrane Database Syst Rev, (6), p. CD007160. doi:10.1002/14651858.CD007160.pub2.
  51. Burls, A., Emparanza, J.I., Quinn, T. and Cabello, J.B. (2010). Oxygen use in acute myocardial infarction: an online survey of health professionals' practice and beliefs. Emerg Med J, 27(4), pp. 283–286. doi:10.1136/emj.2009.077370.
  52. Kunz, R., Nagy, E., Coppus, S.F.P.J., Emparanza, J.I., Hadley, J., Kulier, R., Weinbrenner, S., Arvanitis, T.N., Burls, A., Cabello, J.B., Decsi, T., Horvath, A.R., Walzak, J., Kaczor, M.P., Zanrei, G., Pierer, K., Schaffler, R., Suter, K., Mol, B.W.J. and Khan, K.S. (2009). How far did we get? How far to go? A European survey on postgraduate courses in evidence-based medicine. J Eval Clin Pract, 15(6), pp. 1196–1204. doi:10.1111/j.1365-2753.2009.01268.x.
  53. Burls, A. (2009). Trust me, I am a policy maker. J Public Health (Oxf), 31(4), pp. 470–471. doi:10.1093/pubmed/fdp098.
  54. Cabello, J.B., Emparanza, J.I., Ruiz Garcia, V. and Burls, A. (2009). Oxygen therapy for acute myocardial infarction: a web-based survey of physicians' practices and beliefs. EMERGENCIAS, 21(6), pp. 422–428.
  55. Crilly, M., Glasziou, P., Heneghan, C., Meats, E. and Burls, A. (2009). Does the current version of 'Tomorrow's Doctors' adequately support the role of evidence-based medicine in the undergraduate curriculum? Med Teach, 31(10), pp. 938–944. doi:10.3109/01421590903199650.
  56. Ruiz Garcia, V., Burls, A., Cabello López, J.C.L., Fry-Smith, A.F.S., Gálvez Muñoz, J.G., Jobanputra, P. and Saiz Cuenca, E.S.C. (2009). Certolizumab pegol (CDP870) for rheumatoid arthritis in adults. Cochrane Database of Systematic Reviews, (1) . doi:10.1002/14651858.CD007649.
  57. Teale, A., Deshpande, S. and Burls, A. (2009). Palivizumab and the importance of cost effectiveness. BMJ (Online), 338(7709), pp. 1474–1476.
  58. Kulier, R., Coppus, S.F.P.J., Zamora, J., Hadley, J., Malick, S., Das, K., Weinbrenner, S., Meyerrose, B., Decsi, T., Horvath, A.R., Nagy, E., Emparanza, J.I., Arvanitis, T.N., Burls, A., Cabello, J.B., Kaczor, M., Zanrei, G., Pierer, K., Stawiarz, K., Kunz, R., Mol, B.W.J. and Khan, K.S. (2009). The effectiveness of a clinically integrated e-learning course in evidence-based medicine: a cluster randomised controlled trial. BMC medical education, 9, p. 21. doi:10.1186/1472-6920-9-21.
  59. Wang, D., Cummins, C., Bayliss, S., Sandercock, J. and Burls, A. (2008). Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 12(36), pp. iii–86. doi:10.3310/hta12360.
  60. Glasziou, P., Burls, A. and Gilbert, R. (2008). Evidence based medicine and the medical curriculum. BMJ, 337, p. a1253.
  61. Burls, A., Bayliss, S., Emparanza, J.I. and Quinn, T. (2008). Oxygen therapy for acute myocardial infarction. Cochrane Database of Systematic Reviews, (2) . doi:10.1002/14651858.CD007160.
  62. Kulier, R., Hadley, J., Weinbrenner, S., Meyerrose, B., Decsi, T., Horvath, A.R., Nagy, E., Emparanza, J.I., Coppus, S.F.P.J., Arvanitis, T.N., Burls, A., Cabello, J.B., Kaczor, M., Zanrei, G., Pierer, K., Stawiarz, K., Kunz, R., Mol, B.W.J. and Khan, K.S. (2008). Harmonising evidence-based medicine teaching: a study of the outcomes of e-learning in five European countries. BMC Med Educ, 8, p. 27. doi:10.1186/1472-6920-8-27.
  63. Gilbert, R., Burls, A. and Glasziou, P. (2008). Clinicians also need training in use of research evidence. Lancet, 371(9611), pp. 472–473. doi:10.1016/S0140-6736(08)60231-7.
  64. Coppus, S.F.P.J., Emparanza, J.I., Hadley, J., Kulier, R., Weinbrenner, S., Arvanitis, T.N., Burls, A., Cabello, J.B., Decsi, T., Horvath, A.R., Kaczor, M., Zanrei, G., Pierer, K., Stawiarz, K., Kunz, R., Mol, B.W.J. and Khan, K.S. (2007). A clinically integrated curriculum in evidence-based medicine for just-in-time learning through on-the-job training: the EU-EBM project. BMC Med Educ, 7, p. 46. doi:10.1186/1472-6920-7-46.
  65. Connock, M., Juarez-Garcia, A., Jowett, S., Frew, E., Liu, Z., Taylor, R.J., Fry-Smith, A., Day, E., Lintzeris, N., Roberts, T., Burls, A. and Taylor, R.S. (2007). Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technol Assess, 11(9), pp. 1–iv.
  66. Adi, Y., Juarez-Garcia, A., Wang, D., Jowett, S., Frew, E., Day, E., Bayliss, S., Roberts, T. and Burls, A. (2007). Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation. Health Technol Assess, 11(6), pp. iii–85.
  67. Chen, Y.-.F., Jobanputra, P., Barton, P., Jowett, S., Bryan, S., Clark, W., Fry-Smith, A. and Burls, A. (2006). A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. Health Technol Assess, 10(42), pp. iii–229.
  68. Connock, M., Burls, A., Frew, E., Fry-Smith, A., Juarez-Garcia, A., McCabe, C., Wailoo, A., Abrams, K., Cooper, N., Sutton, A., O'Hagan, A. and Moore, D. (2006). The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review. Health Technol Assess, 10(24), pp. iii–136.
  69. Glasziou, P., Djulbegovic, B. and Burls, A. (2006). Are systematic reviews more cost-effective than randomised trials? Lancet, 367(9528), pp. 2057–2058. doi:10.1016/S0140-6736(06)68919-8.
  70. Burls, A., Jordan, R., Barton, P., Olowokure, B., Wake, B., Albon, E. and Hawker, J. (2006). Vaccinating healthcare workers against influenza to protect the vulnerable--is it a good use of healthcare resources? A systematic review of the evidence and an economic evaluation. Vaccine, 24(19), pp. 4212–4221. doi:10.1016/j.vaccine.2005.12.043.
  71. Jordan, R., Connock, M., Albon, E., Fry-Smith, A., Olowokure, B., Hawker, J. and Burls, A. (2006). Universal vaccination of children against influenza: are there indirect benefits to the community? A systematic review of the evidence. Vaccine, 24(8), pp. 1047–1062. doi:10.1016/j.vaccine.2005.09.017.
  72. Dretzke, J., Burls, A., Bayliss, S. and Sandercock, J. (2006). The clinical effectiveness of pre-hospital intravenous fluid replacement in trauma patients without head injury: A systematic review. Trauma, 8(3), pp. 131–141. doi:10.1177/1460408606071972.
  73. Arrebola, A.P., Kovacs, F., Gestoso, M., Vecchierini, N.M., Del Real Calvo, M.T.G., Pino, M.M., Castell, M.M.S., Ortega, J.A.A., Berstein, S.J., Burls, A., Villar, A.F.G., Kleinbaum, D., Sánchez, J.L., Herranz, A.S., Rodríguez, S.S., Gil, P.S., Santos, V.A., García, A.M., Zamora, J., Sánchez, D.C., Hernández, J.V., Pérez, J.M.M., Castillo, J.A., Torres, A.L., Mancebo, A.R., Rodríguez, M.L.G., Ruiz, J.L.M., Abela, A.L.P., Linares, M.C.U., Sierra, A.F., De Los Monteros, M.T.L.E., Del Castillo, M.L., Osuna, R.A., Romano, E.J., Moreno, A.C., Reyes, M.M., Jaume, M.R., Estela, G.R., Rosselló, J.F., Escudero, A.B., Jáuregui, J.O., Goxencia, J.O., Taberner, P.V., Llobera, J., Rubert, P.T., Urrutia, G., Cosp, X.B., Martin, J.L.R., Alamín, J.M.G., Coello, P.A., Pujadas, C.S., Fuguls, M.R.I., Gómez, J.M., Obregón, S.F., Mata, X.T., Gasoll, A.A., Juárez, M.N., Urquiza, F.P., Villanueva Leal, C., Granell, J.B., Molinero, A.V., Queraltó, J.M., Cañellas, M., Castillo, A.S., Ferrarons, J.T., Sasot, L.O., Fernández, M.C., Galovich, L.A., León, N.G., Villa, L.A.C., Coquillat, P.L.B., Sánchez, J., Munilla, M.G., Delgado, R.C.C., Vicente, M.G., Lázaro, P., Mercado, D., Steel, A.M., Warner, K.F., Conesa, M.D.A., Rubio, J.I.M., Montoya, M.C., Pastor, J.P., De Moya, F.P., García, C.S., Clavijo, M.C., Bermejo, A.L., Isanta, C., Giménez, N., Fernández, C., Sánchez, J.R., Ibáñez, P., Palmer, A.J., Cuadri, M., Suau, M.G., Verd, J.C., Robles, E.D., Adrián, V.R., Urdiroz, M.A.O. and Umbert, S.R. (2005). The interest of the Spanish network of investigators in back pain for rehabilitation physician. Rehabilitacion, 39(4), pp. 185–191. doi:10.1016/S0048-7120(05)74344-9.
  74. Burls, A., Austin, D. and Moore, D. (2005). Commissioning for rare diseases: view from the frontline. BMJ, 331(7523), pp. 1019–1021. doi:10.1136/bmj.331.7523.1019.
  75. Arena, J., Emparanza, J.I., Nogués, A. and Burls, A. (2005). Skin to calcaneus distance in the neonate. Arch Dis Child Fetal Neonatal Ed, 90(4), pp. F328–f331. doi:10.1136/adc.2004.068064.
  76. Dawes, M., Summerskill, W., Glasziou, P., Cartabellotta, A., Martin, J., Hopayian, K., Porzsolt, F., Burls, A., Osborne, J. and Second International Conference of Evidence-Based Health Care Teachers and Developers, (2005). Sicily statement on evidence-based practice. BMC Med Educ, 5(1), p. 1. doi:10.1186/1472-6920-5-1.
  77. Burls, A. and Jobanputra, P. (2004). The trials of anakinra. Lancet, 364(9437), pp. 827–828. doi:10.1016/S0140-6736(04)16999-7.
  78. Burls, A. (2004). Benefits of garden. PSYCHOLOGIST, 17(8), pp. 432–432.
  79. Dretzke, J., Cummins, C., Sandercock, J., Fry-Smith, A., Barrett, T. and Burls, A. (2004). Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus. Health Technol Assess, 8(22), pp. iii–183.
  80. Dretzke, J., Sandercock, J., Bayliss, S. and Burls, A. (2004). Clinical effectiveness and cost-effectiveness of prehospital intravenous fluids in trauma patients. Health Technol Assess, 8(23), pp. iii–103.
  81. Dretzke, J., Cummins, C., Sandercock, J., Fry-Smith, A., Barrett, T. and Burls, A. (2004). Autoantibody testing in children with newly diagnosed type I diabetes mellitus. Health Technology Assessment, 8(22) .
  82. Clark, W., Jobanputra, P., Barton, P. and Burls, A. (2004). The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis. Health Technol Assess, 8(18), pp. iii–105.
  83. Clark, W., Jobanputra, P., Barton, P. and Burls, A. (2004). The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: A systematic review and economic analysis. Health Technology Assessment, 8(18) .
  84. Barton, P., Jobanputra, P., Wilson, J., Bryan, S. and Burls, A. (2004). The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis. Health Technol Assess, 8(11), pp. iii–91.
  85. Blumenauer, B., Judd, M., Cranney, A., Burls, A., Coyle, D., Hochberg, M., Tugwell, P. and Wells, G. (2004). Etanercept for the treatment of rheumatoid arthritis. Praxis, 93(9), p. 329. doi:10.1024/0369-8394.93.9.329.
  86. Jobanputra, P., Wilson, J., Douglas, K. and Burls, A. (2004). A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis. Rheumatology (Oxford), 43(2), pp. 206–210. doi:10.1093/rheumatology/keh003.
  87. Barton, P., Jobanputra, P., Wilson, J., Bryan, S. and Burls, A. (2004). The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis. Health technology assessment (Winchester, England), 8(11), pp. iii, 1–91.
  88. Burls, A. and Sandercock, J. (2003). How to make a compelling submission to NICE: tips for sponsoring organisations. BMJ, 327(7429), pp. 1446–1448. doi:10.1136/bmj.327.7429.1446.
  89. Pitches, D., Burls, A. and Fry-Smith, A. (2003). How to make a silk purse from a sow's ear--a comprehensive review of strategies to optimise data for corrupt managers and incompetent clinicians. BMJ, 327(7429), pp. 1436–1439. doi:10.1136/bmj.327.7429.1436.
  90. Stevens, A., Milne, R. and Burls, A. (2003). Health technology assessment: history and demand. J Public Health Med, 25(2), pp. 98–101.
  91. Clark, W., Raftery, J., Song, F., Barton, P., Cummins, C., Fry-Smith, A. and Burls, A. (2003). Systemic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease. Health Technology Assessment, 7(3) .
  92. Blumenauer, B., Judd, M., Cranney, A., Burls, A., Coyle, D., Hochberg, M., Tugwell, P. and Wells, G. (2003). Etanercept for the treatment of rheumatoid arthritis. Cochrane Database Syst Rev, (4), p. CD004525. doi:10.1002/14651858.CD004525.
  93. Clark, W., Raftery, J., Song, F., Barton, P., Cummins, C., Fry-Smith, A. and Burls, A. (2003). Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease. Health Technol Assess, 7(3), pp. 1–67.
  94. Meads, C., Burls, A. and Bradley, P. (2002). Systematic reviews of specialist epilepsy services. Seizure, 11(2), pp. 90–98. doi:10.1053/seiz.2002.0595.
  95. Cummins, C., Connock, M., Fry-Smith, A. and Burls, A. (2002). A systematic review of effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept. Health Technol Assess, 6(17), pp. 1–43.
  96. Blumenauer, B., Judd, M., Wells, G., Burls, A., Cranney, A., Hochberg, M. and Tugwell, P. (2002). Infliximab for the treatment of rheumatoid arthritis. Cochrane Database Syst Rev, (3), p. CD003785. doi:10.1002/14651858.CD003785.
  97. Jobanputra, P., Barton, P., Bryan, S. and Burls, A. (2002). The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation. Health Technol Assess, 6(21), pp. 1–110.
  98. Burls, A., Clark, W., Stewart, T., Preston, C., Bryan, S., Jefferson, T. and Fry-Smith, A. (2002). Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation. Health Technol Assess, 6(9), pp. 1–87.
  99. Burls, A., Gold, L. and Clark, W. (2001). Systematic review of randomised controlled trials of sildenafil (Viagra) in the treatment of male erectile dysfunction. Br J Gen Pract, 51(473), pp. 1004–1012.
  100. Meads, C., Gold, L. and Burls, A. (2001). How effective is outpatient care compared to inpatient care for the treatment of anorexia nervosa? A systematic review. European Eating Disorders Review, 9(4), pp. 229–241. doi:10.1002/erv.406.
  101. Sandercock, J., Burls, A., Hyde, C., Fry-Smith, A., Barton, P., Bryan, S. and Stewart, A. (2001). Riluzole for motor neurone disease. More trials are needed. BMJ, 322(7297), p. 1305.
  102. Sandercock, J., Burls, A., Hyde, C., Fry-Smith, A., Barton, P., Bryan, S., Stewart, A., Wheatley, K., Gray, R. and Stewart, R. (2001). Riluzole for motor neurone disease [3] (multiple letters). British Medical Journal, 322(7297), pp. 1305–1306.
  103. Jobanputra, P., Parry, D., Fry-Smith, A. and Burls, A. (2001). Effectiveness of autologous chondrocyte transplantation for hyaline cartilage defects in knees: a rapid and systematic review. Health Technol Assess, 5(11), pp. 1–57.
  104. Jordan, R.E., Cummins, C.L., Burls, A.J. and Seukeran, D.C. (2001). Laser resurfacing for facial acne scars. Cochrane database of systematic reviews (Online), (1) .
  105. Stewart, A., Sandercock, J., Bryan, S., Hyde, C., Barton, P.M., Fry-Smith, A. and Burls, A. (2001). The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review. Health Technol Assess, 5(2), pp. 1–97.
  106. Richards, R., Burls, A. and Payne, N. (2000). Cost utility of drugs for multiple sclerosis. Methods used don't calculate true benefit. BMJ, 320(7247), p. 1475.
  107. Bryant, J., Clegg, A., Milne, R., Richards, R., Burls, A., Payne, N., Ellis, S.J., Forbes, R.B. and Swingler, R.J. (2000). Cost utility of drugs for multiple sclerosis. British Medical Journal, 320(7247), pp. 1474–1476.
  108. Jordan, R., Cummins, C. and Burls, A. (2000). Laser resurfacing of the skin for the improvement of facial acne scarring: a systematic review of the evidence. Br J Dermatol, 142(3), pp. 413–423.
  109. Meads, C., Cummins, C., Jolly, K., Stevens, A., Burls, A. and Hyde, C. (2000). Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review. Health Technol Assess, 4(23), pp. 1–153.
  110. Brañas, P., Jordan, R., Fry-Smith, A., Burls, A. and Hyde, C. (2000). Treatments for fatigue in multiple sclerosis: a rapid and systematic review. Health Technol Assess, 4(27), pp. 1–61.
  111. Bradley, P. and Burls, A.J. (1999). Critical Appraisal Skills Programme: A project in critical appraisal skills teaching to improve the quality in health care. Journal of Clinical Governance, 7(2), pp. 88–91.
  112. Stevens, A., Payne, N., Akehurst, R., Milne, R., Gabbay, J. and Burls, A. (1999). DEC methods for appraising new drugs. Paper has errors and omissions. BMJ, 319(7215), pp. 1006–1007.
  113. Campbell, B., Peveler, R., Stein, K., Packer, C., Fidan, D., Stevens, A., Payne, N., Akehurst, R., Milne, R., Gabbay, J., Burls, A., Freemantle, N. and Mason, J. (1999). DEC methods for appraising new drugs (multiple letters) [5]. British Medical Journal, 319(7215), pp. 1005–1007.
  114. Campbell, B., Peveler, R., Stein, K., Packer, C., Fidan, D., Stevens, A., Payne, N., Akehurst, R., Milne, R., Gabbay, J., Burls, A., Freemantle, N. and Mason, J. (1999). DEC methods for appraising new drugs. BMJ, 319(7215), p. 1005. doi:10.1136/bmj.319.7215.1005.
  115. Stevens, A., Payne, N., Akehurst, R., Milne, R., Gabbay, J. and Burls, A. (1999). Paper has errors and omissions. BRITISH MEDICAL JOURNAL, 319(7215), pp. 1006–1006.
  116. Campbell, B. and Peveler, R. (1999). DEC methods for appraising new drugs - Are a foundation for the NICE appraisal committee. BRITISH MEDICAL JOURNAL, 319(7215), pp. 1005–1005.
  117. Burls, A. and Milne, R. (1996). Evaluating the evidence: an introduction. Journal of Clinical Effectiveness, 1(2), pp. 59–62. doi:10.1108/eb020839.
  118. Rogers, M.A., Crockard, H.A., Moskovich, R., Harkey, H.L., Stevens, J.M., Kendall, B.E., Ransford, A.O., Calder, I., Corbett, M., Shipley, M., Sinclair, H., Burls, A., Cornborough, C. and Masters, A.I. (1994). Nystagmus and joint position sensation: Their importance in posterior occipitocervical fusion in rheumatoid arthritis. Spine, 19(1), pp. 16–20.
  119. Burls, A., Subramaniam, K., Lowrie, M.B. and Vrbová, G. (1991). Absence of Nerve - muscle Interaction Influences the Survival of Developing Motoneurons. Eur J Neurosci, 3(3), pp. 216–221.
  120. Price, A., Albarqouni, L., Kirkpatrick, J., Clarke, M., Liew, S.M., Roberts, N. and Burls, A. Patient and Public Involvement in the Design of Clinical Trials: An Overview of Systematic Reviews. Journal of Evaluation in Clinical Practice .

Other

  1. Burls, A. (2016). Publication bias – teaching materials.

    [publisher’s website]

Other Activities

Events/Conferences (36)

  1. Burls A. Certified Bullshit? - A Project to Engagr the Public in Appraising Newspapers' Health Stories. (2012).
    Description: Balliol Interdisciplinary Seminar Series on Leveraging Social Media to Promote Understanding of Health Research
  2. Burls A. How can universities promote Accurate, Complete and Transparent reporting of health research? Freiburg, Germany (2012).
    Description: (Invited Speaker) Equator-Network Symposium
  3. Burls A. Bioethics Seminar on Prioritization for Evidence-Based Health Care. Colegio Médico de A Coruña (2012).
  4. Jensen AM, Stevens R, Kenealy T, Stewart J, Burls A. Is muscle testing a form of biofeedback?: Results from a diagnostic test accuracy study. Baltimore, Maryland, USA (2012).
    Description: Annual Meeting of the Society for Applied Psychophysiology and Biofeedback
  5. Burls A. Positively Uncertaion. London (2012).
    Description: Science Communication Conference, British Science Association.
  6. Jensen AM, Stevens R, Kenealy T, Stewart J, Burls A. The accuracy of kinesiology-style manual muscle testing: A proposed testing protocol and results from a pilot study. Las Vegas, NV, USA (2011).
    Description: In: Johnson C, editor. Association of Chiropractic Colleges Research Agenda Conference (ACC RAC)
  7. Jensen AM, Stevens R, Kenealy T, Stewart J, Burls A. The accuracy of kinesiology-style manual muscle testing to distinguish congruent from incongruent statements under varying levels of blinding: Results from a study of diagnostic test accuracy. Rio de Janiero, Brazil (2011).
    Description: In: Johnson C, editor. World Federation of Chiropractic 11th Biennial Congress
  8. Wale J, Burls A. Engaging with consumers around the world - Learning from the challenges and achievements of the Cochrane Collaboration Consumer Network. Lisbon, Portugal (2009).
    Description: Oral presentation to be given at the GIN Conference
  9. T. Quinn, A. Burls, J. Emparanza, J. Cabello. Oxygen use in acute myocardial infarction: online survey of health professionals' practice and belief. Barcelona, Spain (2009).
    Description: (Oral presentation) European Society of Cardiology Annual Congress
  10. Burls A, Skinner K. The International Network for Knowledge about Wellbeing: An experiment in citizen's epidemiology. St. Petersburg, Russia (2008).
    Description: MEDNET 13th World Congress on the Internet in Medicine
  11. Burls A. Prioritising health care, how can we make ethical equity-efficiency trade-offs. Montreal, Canada (2008).
    Description: (Oral presentation) in HTA Panel on "Does integrating a form of ethical analysis in HTA make a difference in how the HTA is utilized by decision makers" Abstract A-074-0043-00899 HTAi Annual Conference
  12. Burls A. Workshop on teaching statistics without numbers. Taormina, Sicily (2007).
    Description: (Invited Speaker) At the Better Evidence for Better Health Care - 4th International Conference of EBHC Teacher & Developers
  13. Burls A. Estrategias de política sanitaria en la gestión de tratamientos farmacéuticos [Healthcare policies for handling new pharmaceutical treatments] for the meeting on Nuevas tecnologías y sostenibilidad del sistema sanitario [New technologies and the sustainability of the healthcare system. Tenerife, Spain (2007).
    Description: (Invited Speaker) Congreso Nacional de la Sociedad Española de Farmacia Hospitalaria [National Congress of Spanish Society of Hospital Pharmacists]
  14. Burls A, Wang D, Bayliss S, Cummins C, Sandercock J. Immunoprophylaxis for RSV - Identify the children for whom palivizumab is most cost-effective. Barcelona, Spain (2007).
    Description: (Oral presentation) HTAi Annual Conference
  15. Burls A La influencia de la evidencia científica en la toma de decisiones sanitarias [The influence of scientific evidence on health care decisions]. Barcelona, Spain (2007).
    Description: (Invited Speaker) X Congreso LatinCLEN - VI Reunión de la red Cochrane Iberoamericana
  16. Burls A. La evaluación económica [Economic evaluation]. Barcelona, Spain (2007).
    Description: (Invited Speaker) X Congreso LatinCLEN - VI Reunión de la red Cochrane Iberoamericana
  17. Burls A. Putting the public at the heart of research. Wellcome Trust, London (2007).
    Description: (Invited Speaker) James Lind Alliance meeting "Should patients tell researchers what to do? If so, how?" 2007
  18. Burls A, Connock M, Wang D. Does buprenorphine's better safety profile make it a more cost-effective opiate substitute than methadone? Boston, USA (2006).
    Description: (Oral presentation) 28th Annual Meeting of the Society for Medical Decision Making
  19. Juarez-Garcia A, Jowett S, Roberts T, Frew E, Taylor R, Connock M, Burls A, Taylor R. The cost-effectiveness of methadone and buprenorphine maintenance therapy for the management of opioid dependence. Boston, USA (2006).
    Description: (Oral presentation) 28th Annual Meeting of the Society for Medical Decision Making
  20. Burls A. La gestión del conocimiento [Knowledge management]. Palacio Miramar, San Sebastian (2006).
    Description: (Invited Speaker) Jornada de difusión de Medicina Basada en la Evidencia
  21. Burls A. La lectura crítica de una evaluación económica [The critical appraisal of economic evaluations]. San Sebastian, Spain (2006).
    Description: (Invited Speaker) Jornada de difusión de Medicina Basada en la Evidencia, Palacio Miramar
  22. Burls A. Using evidence to inform political, policy and managerial health services decisions. Bologna, Italy (2006).
    Description: (Invited Speaker) 1a Conferenza Nazionale GIMBE® Dall'Evidence-based Practice alla Clinical Governance
  23. Barton P, Jobanputra P, Bryan S, Burls A. Application of local search methods in cost-effectiveness analysis: the case of rheumatoid arthritis. San Francisco, USA (2005).
    Description: (Oral presentation) Society for Medical Decision Making Annual Conference
  24. Jordan R, Connock M, Albon E, Fry-Smith A, Burls A, Olowokure B, Hawker J. Vaccinating children against influenza: A systematic review of the evidence for community protection. Copenhagen, Denmark (2005).
    Description: (Oral presentation) European Respiratory Society Congress
  25. Jordan R, Connock M, Albon E, Fry-Smith A, Burls A, Olowokure B, Hawker J. Vaccinating children against influenza: A systematic review of the evidence for community protection. London, UK (2005).
    Description: Invited contribution. (Oral presentation) Five Nations Health Protection Conference
  26. Burls A. Quality of life and cost-effectiveness in rare disorders. El Escorial, Spain (2005).
    Description: (Invited Speaker) Keynote oral presentation for the 1o Hispano-Luso Symposium on Lysosomal Storage Diseases
  27. Burls A. Sesiones bibliográficas en Medicina Basada en la Evidencia. [Journal Clubs for promoting evidence-based medicine. Sevilla, Spain (2004).
    Description: (Invited Speaker) XXIV Congreso de la Sociedad Española de Medicina de Familia y Comunitaria
  28. Burls A. NICE - El Instituto Nacional para la Excelencia Clínica - implicaciones para atención primaria [The National Institute for Clinical Excellence and its impact on primary care.]. Sevilla, Spain (2004).
    Description: Oral presentation (Invited Speaker) XXIV Congreso de la Sociedad Española de Medicina de Familia y Comunitaria
  29. Burls A. Methods for capturing evidence about patient and carer experience of illness and technologies. Sevilla, Spain (2004).
    Description: (Oral presentation) HTAi Annual Conference. Krakow, Poland. 2004
    Burls A. Lectura crítica para el paciente. [Critical appraisals skills workshop for patients] (Invited Speaker) XXIV Congreso de la Sociedad Española de Medicina de Familia y Comunitaria
  30. Burls A. Methods for capturing evidence about patient and carer experience of illness and technologies. Birmingham, UK (2004).
    Description: (Invited Speaker) NICE Annual Conference - Clinical Excellence
  31. Burls A. Levels of Evidence. Oral presentation. Rüttihubelbad, Switzerland (2003).
    Description: (Invited Speaker) Comparative Observational Studies in Therapeutic Research: Approach to the Development of Guidelines for Research and Reporting, Symposium
  32. Burls A. Sign-posting the future in evidence-based health-care. Sicily, Italy (2003).
    Description: (Invited Speaker) 2nd International Conference of Evidence-Based Health-Care Teachers & Developers Conference
  33. Burls A. Medicina Basada en Evidencias ¿Qué es? [What is evidence-based medicine?]. Quito, Ecuador (2002).
    Description: (Invited Speaker) Annual Ecuatorian Congress for Intensive Care
  34. Burls A. Calidad en la atención médica. [Improving the quality of intensive care]. Quito, Ecuador (2002).
    Description: (Invited Speaker) Annual Ecuatorian Congress for Intensive Care
  35. Burls A. Rapid reviews in the NHS are we doing more harm than good? Oxford, UK (2002).
    Description: (Invited Speaker) 3rd Systematic Review Symposium
  36. Burls A. Understanding scientific evidence. Barcelona, Spain
    Description: (Invited Speaker) HTAi Information Research Group Meeting, HTAi Annual Conference

Find us

City, University of London

Northampton Square

London EC1V 0HB

United Kingdom

Back to top

City, University of London is an independent member institution of the University of London. Established by Royal Charter in 1836, the University of London consists of 18 independent member institutions with outstanding global reputations and several prestigious central academic bodies and activities.